CN106492006A - A kind of treat health product of diabetes and preparation method thereof - Google Patents
A kind of treat health product of diabetes and preparation method thereof Download PDFInfo
- Publication number
- CN106492006A CN106492006A CN201610937925.8A CN201610937925A CN106492006A CN 106492006 A CN106492006 A CN 106492006A CN 201610937925 A CN201610937925 A CN 201610937925A CN 106492006 A CN106492006 A CN 106492006A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- herba
- health product
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 34
- 241001251068 Formica fusca Species 0.000 claims abstract description 21
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241000207199 Citrus Species 0.000 claims abstract description 18
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 18
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 16
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 claims abstract description 16
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 claims abstract description 16
- 239000000706 filtrate Substances 0.000 claims description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000001914 filtration Methods 0.000 claims description 30
- 239000000047 product Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 244000276331 Citrus maxima Species 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 235000013372 meat Nutrition 0.000 claims description 7
- 238000002604 ultrasonography Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 6
- 235000001759 Citrus maxima Nutrition 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 5
- 239000004327 boric acid Substances 0.000 claims description 5
- 238000001354 calcination Methods 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- -1 1~2h of reflux Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 244000205754 Colocasia esculenta Species 0.000 claims 1
- 235000006481 Colocasia esculenta Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052711 selenium Inorganic materials 0.000 abstract description 5
- 239000011669 selenium Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 2
- 239000011707 mineral Substances 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 10
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001620634 Roger Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229930185803 charantin Natural products 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001610 euglycemic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of treat health product of diabetes and preparation method thereof.Wherein, described health product are made up of each component of following weight：20～25 parts of Formica fusca, 15～18 parts of Herba Dendrobii, 10～12 parts of Ganoderma, 4～6 parts of Fructus Lycii, 5～9 parts of Fructus Momordicae charantiae, 3～6 parts of Radix Bupleuri, 6～8 parts of Herba mesonae chinensiss, 6～9 parts of Fructus Citri grandiss, 2～4 parts of Citrus, 6～8 parts of Herba bromi japonici, 2～5 parts of Rhizoma Steudnerae Henryanae, 3～5 parts of Folium Mori, 4～6 parts of Fructus Arctii, 0.4～0.8 part of Maifanitum, 0.6～0.8 part of nano ferriferrous oxide, 3～6 parts of Rhizoma amorphophalli powder, 0.3～0.6 part of Pulvis Talci.The health product take full advantage of the function of Chinese medicine and mineral drug, in combination with DFS and the effect rich in selenium material, enhance prophylactic-therapeutic effect of the health product to diabetes.
Description
Technical field
The present invention relates to a kind of treat health product of diabetes and preparation method thereof, belong to technical field of Chinese medicines.
Background technology
Diabetes are a kind of metabolic diseases being characterized with hyperglycemia, and pathogenesis are that in patient's body insulin secretion is not
Foot or Insulin receptor INSR dysfunction, clinical manifestation are empty stomach or post-prandial glycemia rising, glycosuria and hyperlipemia.Diabetes duration
The hyperglycemia that phase is present, causes various tissues, particularly eye, kidney, heart, blood vessel, the chronic lesion of nerve, dysfunction, sternly
The Health and Living quality of the mankind is threaten again.
Diabetes are one of high morbidities of modern society, and not only population risk has rising trend, and age of onset also becomes
To rejuvenation.How diabetes are prevented and treated, it has also become the focus of those skilled in the art's research.At present, treatment diabetes are mainly adopted
With insulin therapy and Drug therapy, the maximum untoward reaction of insulin therapy is hypoglycemia；And Drug therapy is used mostly mouth
Take Drug therapy such as：Sulfonamides, biguanideses, glucosidase inhibitor, Lie Nai and euglycemic agent etc., but long-term taking is not
Only larger to liver, injury of kidney, and drug resistance, recurrence is easily produced, relative cost is costly, and medicine time is long, is difficult from root
Solve problem in sheet.However, TCM Treatment of Diabetes improve symptom substantially, persistent, Small side effects have played Chinese medicine tune
The advantage that reason is effected a permanent cure, protects internal organ, reduces the side effect of Western medicine, than Western medicine, have irreplaceable superiority.
Despite this, but Chinese medicine formulas relatively more at present can not be effected a radical cure, and curative effect can not be satisfactory.Therefore, continual exploitation
It is very valuable with TCM Treatment of Diabetes is developed.
Content of the invention
For above-mentioned the deficiencies in the prior art, the technical problem to be solved is to propose one kind to treat diabetes
Health product and preparation method thereof.
A kind of health product for treating diabetes, are made up of each component of following weight：20～25 parts of Formica fusca, stone
15～18 parts of dry measure used in former times, 10～12 parts of Ganoderma, 4～6 parts of Fructus Lycii, 5～9 parts of Fructus Momordicae charantiae, 3～6 parts of Radix Bupleuri, 6～8 parts of Herba mesonae chinensiss, Fructus Citri grandiss 6～
9 parts, 2～4 parts of Citrus, 6～8 parts of Herba bromi japonici, 2～5 parts of Rhizoma Steudnerae Henryanae, 3～5 parts of Folium Mori, 4～6 parts of Fructus Arctii, 0.4～0.8 part of Maifanitum,
0.6～0.8 part of nano ferriferrous oxide, 3～6 parts of Rhizoma amorphophalli powder, 0.3～0.6 part of Pulvis Talci.
Preferably,
A kind of health product for treating diabetes, are made up of each component of following weight：22 parts of Formica fusca, Herba Dendrobii 17
Part, 11 parts of Ganoderma, 5 parts of Fructus Lycii, 7 parts of Fructus Momordicae charantiae, 5 parts of Radix Bupleuri, 7 parts of Herba mesonae chinensiss, 8 parts of Fructus Citri grandiss, 3 parts of Citrus, 7 parts of Herba bromi japonici, Rhizoma Steudnerae Henryanae 4
Part, 4 parts of Folium Mori, 5 parts of Fructus Arctii, 0.6 part of Maifanitum, 0.7 part of nano ferriferrous oxide, 5 parts of Rhizoma amorphophalli powder, 0.4 part of Pulvis Talci.
Described Fructus Citri grandiss include you meat and pomelo peel.
The preparation method of the health product of described treatment diabetes, comprises the following steps：
1) Maifanitum, Pulvis Talci are first respectively placed in 40～60min of calcining in 700 DEG C and 1000 DEG C of Muffle furnace, then
800～1000 mesh being ground into, finally 15～20min being soaked with boric acid, centrifugation is filtered, dried, standby；
2) Formica fusca, Herba bromi japonici, shaddock peel powder are broken into 100～120 mesh first, and by Formica fusca, oatmeal microwave drying 2～
After 5min, mixing adds 5～10 times of 60～80% ethanol to soak 20～30min, and the temperature for then adjusting feed liquid is 50～60
DEG C, pH is 5～6, is simultaneously introduced the 1～2h of protease hydrolyzed for accounting for feed liquid weight 0.1～0.3%, and finally, sterilizing is filtered, obtained
Filtrate 1 is standby；
3) Herba Dendrobii, Ganoderma, Fructus Lycii, Radix Bupleuri and Folium Mori are broken into 60～100 mesh first, are subsequently adding medicinal powder weight 6～8
Times distilled water, in 80～90 DEG C of 30～50min of water extraction, filter, then add in filtering residue 6～8 times of filtering residue weight 70～
80% ethanol, 1～2h of reflux, extract, last merging filtrate obtain filtrate 2, standby；
4) first Herba mesonae chinensiss and Fructus Arctii are broken into 60～80 mesh, are subsequently adding 60～70% ethanol of 6～8 times of medicinal powder weight
Extract, filter, in filtering residue, then add the distilled water of 6～8 times of filtering residue weight, be placed in 30～50kHz of supersonic frequency, temperature
Supersound extraction is carried out at 30～40 DEG C, 10～15min is extracted, and last merging filtrate obtains filtrate 3, standby；
5) first Fructus Momordicae charantiae, you meat, Citrus and Rhizoma Steudnerae Henryanae are squeezed the juice, and filter, and then add the steaming of 6～8 times of filtering residue weight in filtering residue
Distilled water, is placed in 30～40kHz of supersonic frequency, carries out supersound extraction at 30～40 DEG C of temperature, extracts 6～9min, finally merges
Squeeze the juice, filtrate, obtain filtrate 4, standby；
6) first filtrate 1,2,3,4 is merged, is subsequently adding through step 1) Maifanitum for obtaining is processed, 4～8min is soaked, most
Sequentially added through step 1 afterwards) Pulvis Talci, nano ferriferrous oxide and the Rhizoma amorphophalli powder for obtaining is processed, and surpass in the state of stirring
After 3～6min of sound, concentration is dried, is obtained final product.
Formica fusca, scientific name, Polyhachis vicina Roger, are the Formica fuscas of medicine-food two-purpose, its contain protein, aminoacid, vitamin,
Trace element, triterpenoid compound, formic acid, adenosine triphosphate (ATP) and the cursive script formaldehyde that cannot manually synthesize, interleukin 8
Plain -2 grade various bioactivators, especially triterpenoid compound have pain relieving, calmness, suppress histamine releasing, removing toxic substances, protect
The functions such as liver, poisoning tumor cell, have significant blood pressure lowering and effect for reducing blood fat, while also having suppression to tumor cells such as hepatosarcoma
Make and use, be the best material of anticancer, have to hypertension, hyperlipidemia, insomnia and various respiratory systemic disease treatment well to make
With.
Herba Dendrobii, property slightly sweet flavor are micro- salty, tremble with fear, return stomach, kidney, lung meridian.Reinforcing stomach reg fluid, nourishing YIN and clearing away heat.For impairment of yin body fluid deficiency, xerostomia
Excessive thirst, lack of appetite are retched, after being ill deficiency-heat, poor vision.
Ganoderma, have functions that invigorating QI and tranquilization, relieving cough and asthma, coughs to dizziness sleeplessness, shortness of breath and palpitation, neurasthenia, asthenia
Breathe heavily, life lengthening has certain effect.
Lycium barbarum polysaccharide can be remarkably reinforced the activity of superoxide dismutase in damaged islet cells (SOD), improve islets of langerhans thin
The oxidation resistance of born of the same parents, mitigates damage of the peroxide to cell, reduces interior dialdehyde growing amount, and this shows lycium barbarum polysaccharide to islets of langerhans
Cell has certain protective effect.
The Fresh sap of Fructus Momordicae charantiae, the material containing Charantin with similar insulin, with good hypoglycemic activity, is sugar
The ultimate food of urine patient.
Radix Bupleuri, meridian distribution of property and flavor, be slightly cold, sweet, Return liver, stomach, cure mainly clearind deficient heat, dispelling fever with infantile malnutrition.For fever due to yin deficiency, hectic fever due to YIN-deficiency labor
Heat, children's infantile malnutrition with fever.
Herba mesonae chinensiss, cold in nature, sweet in the mouth, light, relieve summer heat, heat clearing away, removing heat from blood, removing toxic substances, diabetes, jaundice can be treated, let out
Rush down, the disease such as dysentery, hypertension, acute nephritiss.
Fresh you meat is due to the composition containing similar insulin, the even more ultimate food of diabeticss.It can promote appetite,
Control the diseases such as dyspepsia, qi-regulating eliminating stagnation.Containing abundant vitamin C in the sarcocarp of Citrus, vitamin C can improve the immunity of body
Power, while Citrus can also reduce the probability for suffering from cardiovascular disease, obesity and diabetes.Additionally, pomelo peel, Citrus, Herba bromi japonici, rich
Contain dietary fiber, and dietary fiber has different physiological roles, can prevent and treat diabetes, hypertension etc., is that a class is ideal
Functional health care product.
Rhizoma Steudnerae Henryanae, mainly contains protein, vitamin, mineral element, selenium element and anthocyanidin.Wherein content of cellulose is high,
This kind of material can increase faecal volume, promote enterogastric peristalsis, clear up mucus, pneumatosis and the putrefaction being detained in enteric cavity, discharge excrement
Just the noxious substance and carcinogen in, keeps stool unimpeded, improves digestive tract environment, prevent the generation of gastroenteropathy；Selenium
Element is easily absorbed by the body, and effectively stays in serum, repairs cardiac muscle, and enhancing human body immunity power is removed
Free radical, the synthesis of DNA and the division of cancerous cell and growth in anticancer prevent gastric cancer, the generation of the disease such as hepatocarcinoma；
Anthocyanidin is natural potent free radical scavenger.
Folium Mori, bitter, sweet, tremble with fear.Return lung, Liver Channel.Dispelling wind and heat pathogens, liver heat removing and eyesight improving.Folium Mori are rich in rare element organic selenium, germanium,
It is natural powerful antioxidant, interior free yl can be removed, makes the toxin that is accumulated in human body and waste oxidized, increase blood
In oxygen content, enhance metabolism and microcirculation.Simultaneously for hyperlipidemia, hyperglycemia, diabetes, fatty liver, coronary heart disease, height
The rehabilitation of the postoperative chemicotherapy patient of blood pressure, the treatment of Combined hepatitis A and B vaccine and cancer has extraordinary assosting effect.
Fructus Arctii has the effects such as treatment diabetes, hypertension, hyperlipidemia, anticancer.Can blood sugar lowering, blood pressure lowering, blood fat, treatment
The effects such as insomnia, raising body immunity.
Maifanitum, with the harmful element and impurity in adsorbing and extracting liquid, can reduce the side effect of Chinese medicine.Meanwhile, Maifanitum
Also have and strengthen myocardial contraction, the efficiency of decreased heart rate has to the immunity and promotion growth in humans's development that improve human body aobvious
Works is used；The internal toxin of exclusion can be played, accelerates ion exchange, the effect of blood circulation promoting and washed cell；Simultaneously can also
Strengthen skin elasticity, improve the flexible function of blood capillary, remove fatigue, health invigorating, to prophylaxis of hypertension, senile blood vessel
Hardening has certain curative effect.
Nano ferriferrous oxide cure mainly calm the nerves, hearing-improing and eyesight improving, helping inspiration to relieve asthma, for having a dizzy spell, blurring of vision, tinnitus,
Deafness, kidney deficiency asthma, infantile convulsion, severe palpitation etc..Simultaneously, moreover it is possible to form magnetic macromolecular microsphere with Rhizoma amorphophalli powder, increase between medicine
The compatibility, so that improve therapeutic effect.In addition, Rhizoma amorphophalli powder has very strong water absorption, after water suction, volume is inflatable, easy quilt after food
Digest and assimilate, and cholesterol and bile acid can be adsorbed, to reducing blood pressure, reducing cardiovascular diseasess' outbreak has certain effectiveness.Rhizoma amorphophalli is also
Containing water soluble dietary fiber, this fiber is to suppressing post-prandial glycemia to raise very effectively, thus Rhizoma amorphophalli powder is diabeticss
Preferable antihypelipidemic foodstuff.Additionally, Pulvis Talci also has heat clearing away, eliminating dampness by diuresis, the function of sharp key.
Compared with prior art, the invention has the beneficial effects as follows：
1st, the present invention takes full advantage of the function of Chinese medicine and mineral drug, in combination with DFS and richness
Effect containing selenium material, overcomes the defect of traditional pure Chinese medicine health product, enhances prophylactic-therapeutic effect of the health product to diabetes.
2 present invention utilizes nano ferriferrous oxide and Rhizoma amorphophalli powder formation magnetic macromolecular microsphere, increase between medicine
The compatibility, improves the overall efficacy of medicine；Meanwhile, Rhizoma amorphophalli powder has very strong water absorption, and after water suction, volume is inflatable, so as to slow
Slow release, plays a part of controlled release drug, it is ensured that lasting medicine.
Specific embodiment
Embodiment 1
A kind of health product for treating diabetes, are made up of each component of following weight：22 parts of Formica fusca, Herba Dendrobii 17
Part, 11 parts of Ganoderma, 5 parts of Fructus Lycii, 7 parts of Fructus Momordicae charantiae, 5 parts of Radix Bupleuri, 7 parts of Herba mesonae chinensiss, 8 parts of Fructus Citri grandiss, 3 parts of Citrus, 7 parts of Herba bromi japonici, Rhizoma Steudnerae Henryanae 4
Part, 4 parts of Folium Mori, 5 parts of Fructus Arctii, 0.6 part of Maifanitum, 0.7 part of nano ferriferrous oxide, 5 parts of Rhizoma amorphophalli powder, 0.4 part of Pulvis Talci.
The preparation method of the health product of described treatment diabetes, comprises the following steps：
1) Maifanitum, Pulvis Talci are first respectively placed in calcining 50min in 700 DEG C and 1000 DEG C of Muffle furnace, are then crushed
Into 1000 mesh, finally 18min is soaked with boric acid, centrifugation is filtered, dried, standby；
2) Formica fusca, Herba bromi japonici, shaddock peel powder are broken into 120 mesh first, and by Formica fusca, oatmeal microwave drying 3min after,
Mixing, adds 8 times of 70% ethanol immersion 25min, and the temperature for then adjusting feed liquid is 55 DEG C, and pH is 5.5, is simultaneously introduced and accounts for material
The protease hydrolyzed 1.5h of liquid weight 0.2%, finally, sterilizing is filtered, obtains filtrate 1, standby；
3) Herba Dendrobii, Ganoderma, Fructus Lycii, Radix Bupleuri and Folium Mori are broken into 80 mesh first, are subsequently adding the distillation of 7 times of medicinal powder weight
Water, in 85 DEG C of water extraction 40min, filters, and then adds 75% ethanol of 7 times of filtering residue weight in filtering residue, reflux, extract, 1.5h, most
Merging filtrate, obtains filtrate 2 afterwards, standby；
4) first Herba mesonae chinensiss and Fructus Arctii are broken into 80 mesh, and 65% ethanol for being subsequently adding 7 times of medicinal powder weight is extracted, and is filtered,
Then the distilled water of 7 times of filtering residue weight is added in filtering residue, is placed in supersonic frequency 40kHz, is carried out ultrasound and carry at 35 DEG C of temperature
Take, extract 12min, last merging filtrate obtains filtrate 3, standby；
5) first Fructus Momordicae charantiae, you meat, Citrus and Rhizoma Steudnerae Henryanae are squeezed the juice, and filter, and then add the distillation of 7 times of filtering residue weight in filtering residue
Water, is placed in supersonic frequency 35kHz, carries out supersound extraction at 35 DEG C of temperature, extracts 8min, and finally merging is squeezed the juice, filtrate, obtains
Filtrate 4 is standby；
6) first filtrate 1,2,3,4 is merged, is subsequently adding through step 1) Maifanitum for obtaining is processed, 6min is soaked, finally
Sequentially add through step 1) process Pulvis Talci, nano ferriferrous oxide and the Rhizoma amorphophalli powder for obtaining, and ultrasound in the state of stirring
After 5min, concentration is dried, is obtained final product.
Embodiment 2
A kind of health product for treating diabetes, are made up of each component of following weight：20 parts of Formica fusca, Herba Dendrobii 15
Part, 10 parts of Ganoderma, 4 parts of Fructus Lycii, 5 parts of Fructus Momordicae charantiae, 3 parts of Radix Bupleuri, 6 parts of Herba mesonae chinensiss, 6 parts of Fructus Citri grandiss, 2 parts of Citrus, 6 parts of Herba bromi japonici, Rhizoma Steudnerae Henryanae 2
Part, 3 parts of Folium Mori, 4 parts of Fructus Arctii, 0.4 part of Maifanitum, 0.6 part of nano ferriferrous oxide, 3 parts of Rhizoma amorphophalli powder, 0.3 part of Pulvis Talci.
The preparation method of the health product of described treatment diabetes, comprises the following steps：
1) Maifanitum, Pulvis Talci are first respectively placed in calcining 40min in 700 DEG C and 1000 DEG C of Muffle furnace, are then crushed
Into 800 mesh, finally 15min is soaked with boric acid, centrifugation is filtered, dried, standby；
2) Formica fusca, Herba bromi japonici, shaddock peel powder are broken into 100 mesh first, and by Formica fusca, oatmeal microwave drying 2min after,
Mixing, adds 5 times of 60% ethanol immersion 20min, and the temperature for then adjusting feed liquid is 50 DEG C, and pH is 5, is simultaneously introduced and accounts for feed liquid
The protease hydrolyzed 1h of weight 0.1%, finally, sterilizing is filtered, obtains filtrate 1, standby；
3) Herba Dendrobii, Ganoderma, Fructus Lycii, Radix Bupleuri and Folium Mori are broken into 60 mesh first, are subsequently adding the distillation of 6 times of medicinal powder weight
Water, in 80 DEG C of water extraction 30min, filters, and then adds 70% ethanol of 6 times of filtering residue weight in filtering residue, reflux, extract, 1h, finally
Merging filtrate, obtains filtrate 2, standby；
4) first Herba mesonae chinensiss and Fructus Arctii are broken into 60 mesh, and 60% ethanol for being subsequently adding 6 times of medicinal powder weight is extracted, and is filtered,
Then the distilled water of 6 times of filtering residue weight is added in filtering residue, is placed in supersonic frequency 30kHz, is carried out ultrasound and carry at 30 DEG C of temperature
Take, extract 10min, last merging filtrate obtains filtrate 3, standby；
5) first Fructus Momordicae charantiae, you meat, Citrus and Rhizoma Steudnerae Henryanae are squeezed the juice, and filter, and then add the distillation of 6 times of filtering residue weight in filtering residue
Water, is placed in supersonic frequency 30kHz, carries out supersound extraction at 30 DEG C of temperature, extracts 6min, and finally merging is squeezed the juice, filtrate, obtains
Filtrate 4 is standby；
6) first filtrate 1,2,3,4 is merged, is subsequently adding through step 1) Maifanitum for obtaining is processed, 4min is soaked, finally
Sequentially add through step 1) process Pulvis Talci, nano ferriferrous oxide and the Rhizoma amorphophalli powder for obtaining, and ultrasound in the state of stirring
After 3min, concentration is dried, is obtained final product.
Embodiment 3
A kind of health product for treating diabetes, are made up of each component of following weight：25 parts of Formica fusca, Herba Dendrobii 18
Part, 12 parts of Ganoderma, 6 parts of Fructus Lycii, 9 parts of Fructus Momordicae charantiae, 6 parts of Radix Bupleuri, 8 parts of Herba mesonae chinensiss, 9 parts of Fructus Citri grandiss, 4 parts of Citrus, 8 parts of Herba bromi japonici, Rhizoma Steudnerae Henryanae 5
Part, 5 parts of Folium Mori, 6 parts of Fructus Arctii, 0.8 part of Maifanitum, 0.8 part of nano ferriferrous oxide, 6 parts of Rhizoma amorphophalli powder, 0.6 part of Pulvis Talci.
The preparation method of the health product of described treatment diabetes, comprises the following steps：
1) Maifanitum, Pulvis Talci are first respectively placed in calcining 60min in 700 DEG C and 1000 DEG C of Muffle furnace, are then crushed
Into 1000 mesh, finally 20min is soaked with boric acid, centrifugation is filtered, dried, standby；
2) Formica fusca, Herba bromi japonici, shaddock peel powder are broken into 120 mesh first, and by Formica fusca, oatmeal microwave drying 5min after,
Mixing, adds 10 times of 80% ethanol immersion 30min, and the temperature for then adjusting feed liquid is 60 DEG C, and pH is 6, is simultaneously introduced and accounts for material
The protease hydrolyzed 2h of liquid weight 0.3%, finally, sterilizing is filtered, obtains filtrate 1, standby；
3) Herba Dendrobii, Ganoderma, Fructus Lycii, Radix Bupleuri and Folium Mori are broken into 100 mesh first, are subsequently adding the steaming of 8 times of medicinal powder weight
Distilled water, in 90 DEG C of water extraction 50min, filters, and then adds 80% ethanol of 8 times of filtering residue weight in filtering residue, reflux, extract, 2h, most
Merging filtrate, obtains filtrate 2 afterwards, standby；
4) first Herba mesonae chinensiss and Fructus Arctii are broken into 80 mesh, and 70% ethanol for being subsequently adding 8 times of medicinal powder weight is extracted, and is filtered,
Then the distilled water of 8 times of filtering residue weight is added in filtering residue, is placed in supersonic frequency 50kHz, is carried out ultrasound and carry at 40 DEG C of temperature
Take, extract 15min, last merging filtrate obtains filtrate 3, standby；
5) first Fructus Momordicae charantiae, you meat, Citrus and Rhizoma Steudnerae Henryanae are squeezed the juice, and filter, and then add the distillation of 8 times of filtering residue weight in filtering residue
Water, is placed in supersonic frequency 40kHz, carries out supersound extraction at 40 DEG C of temperature, extracts 9min, and finally merging is squeezed the juice, filtrate, obtains
Filtrate 4 is standby；
6) first filtrate 1,2,3,4 is merged, is subsequently adding through step 1) Maifanitum for obtaining is processed, 8min is soaked, finally
Sequentially add through step 1) process Pulvis Talci, nano ferriferrous oxide and the Rhizoma amorphophalli powder for obtaining, and ultrasound in the state of stirring
After 6min, concentration is dried, is obtained final product.
(comparative example 1 is only that with the difference of embodiment 1 formula is as follows in comparative example 1 to comparative example 1, remaining same embodiment
1).
A kind of health product for treating diabetes, are made up of each component of following weight：22 parts of Formica fusca, Herba Dendrobii 17
Part, 11 parts of Ganoderma, 5 parts of Fructus Lycii, 7 parts of Fructus Momordicae charantiae, 5 parts of Radix Bupleuri, 7 parts of Herba mesonae chinensiss, 8 parts of Fructus Citri grandiss, 3 parts of Citrus, 7 parts of Herba bromi japonici, Rhizoma Steudnerae Henryanae 4
Part, 4 parts of Folium Mori, 5 parts of Fructus Arctii.
(comparative example 2 is only that with the difference of embodiment 1 formula is as follows in comparative example 2 to comparative example 2, remaining same embodiment
1).
A kind of health product for treating diabetes, are made up of each component of following weight：17 parts of Herba Dendrobii, Ganoderma 11
Part, 5 parts of Fructus Lycii, 7 parts of Fructus Momordicae charantiae, 5 parts of Radix Bupleuri, 8 parts of Fructus Citri grandiss, 3 parts of Citrus, 7 parts of Herba bromi japonici, 4 parts of Folium Mori, 5 parts of Fructus Arctii, Maifanitum 0.6
Part, 0.7 part of nano ferriferrous oxide, 5 parts of Rhizoma amorphophalli powder, 0.4 part of Pulvis Talci.
(comparative example 3 is only that with the difference of embodiment 1 preparation method is that water extraction method is extracted in comparative example 3 to comparative example 3
Chinese medicine, remaining with embodiment 1).
With embodiment 1,2,3 and comparative example 1,2,3 as treatment diabetes medicament, take in the morning and evening, continuously take one
Individual month, the therapeutic effect of drug treatment of diabetic is recorded, 1 is the results are shown in Table.
1 therapeutic effect of table
Certainly, it is that the preferred embodiments of the disclosure is described in detail above, the present invention is limited with this not
Practical range, the equivalence changes made by all principles under this invention, construction and structure, all should be covered by the present invention protection
In the range of.
Claims (3)
1. a kind of health product for treating diabetes, it is characterised in that：It is made up of each component of following weight：Formica fusca 20
～25 parts, 15～18 parts of Herba Dendrobii, 10～12 parts of Ganoderma, 4～6 parts of Fructus Lycii, 5～9 parts of Fructus Momordicae charantiae, 3～6 parts of Radix Bupleuri, Herba mesonae chinensiss 6～8
Part, 6～9 parts of Fructus Citri grandiss, 2～4 parts of Citrus, 6～8 parts of Herba bromi japonici, 2～5 parts of Rhizoma Steudnerae Henryanae, 3～5 parts of Folium Mori, 4～6 parts of Fructus Arctii, Maifanitum
0.4～0.8 part, 0.6～0.8 part of nano ferriferrous oxide, 3～6 parts of Rhizoma amorphophalli powder, 0.3～0.6 part of Pulvis Talci.
2. according to claim 1 treatment diabetes health product, it is characterised in that：Each group by following weight
Divide and make：22 parts of Formica fusca, 17 parts of Herba Dendrobii, 11 parts of Ganoderma, 5 parts of Fructus Lycii, 7 parts of Fructus Momordicae charantiae, 5 parts of Radix Bupleuri, 7 parts of Herba mesonae chinensiss, Fructus Citri grandiss 8
Part, 3 parts of Citrus, 7 parts of Herba bromi japonici, 4 parts of Rhizoma Steudnerae Henryanae, 4 parts of Folium Mori, 5 parts of Fructus Arctii, 0.6 part of Maifanitum, 0.7 part of nano ferriferrous oxide, evil spirit
5 parts of taro powder, 0.4 part of Pulvis Talci.
3. according to claim 1 treatment diabetes health product preparation method, it is characterised in that：Including following step
Suddenly：
1) Maifanitum, Pulvis Talci are first respectively placed in 40～60min of calcining in 700 DEG C and 1000 DEG C of Muffle furnace, are then crushed
Into 800～1000 mesh, finally 15～20min is soaked with boric acid, centrifugation is filtered, dried, standby；
2) Formica fusca, Herba bromi japonici, shaddock peel powder are broken into 100～120 mesh first, and by Formica fusca, oatmeal 2～5min of microwave drying
Afterwards, mix, add 5～10 times of 60～80% ethanol to soak 20～30min, the temperature for then adjusting feed liquid is 50～60 DEG C,
PH is 5～6, is simultaneously introduced the 1～2h of protease hydrolyzed for accounting for feed liquid weight 0.1～0.3%, and finally, sterilizing is filtered, filtered
Liquid 1, standby；
3) Herba Dendrobii, Ganoderma, Fructus Lycii, Radix Bupleuri and Folium Mori are broken into 60～100 mesh first, are subsequently adding 6～8 times of medicinal powder weight
Distilled water, in 80～90 DEG C of 30～50min of water extraction, filters, and then adds the 70～80% of 6～8 times of filtering residue weight in filtering residue
Ethanol, 1～2h of reflux, extract, last merging filtrate obtain filtrate 2, standby；
4) first Herba mesonae chinensiss and Fructus Arctii are broken into 60～80 mesh, and 60～70% ethanol for being subsequently adding 6～8 times of medicinal powder weight are carried
Take, filter, in filtering residue, then add the distilled water of 6～8 times of filtering residue weight, be placed in 30～50kHz of supersonic frequency, temperature 30
Supersound extraction is carried out at～40 DEG C, 10～15min is extracted, and last merging filtrate obtains filtrate 3, standby；
5) first Fructus Momordicae charantiae, you meat, Citrus and Rhizoma Steudnerae Henryanae are squeezed the juice, and filter, and then add the distilled water of 6～8 times of filtering residue weight in filtering residue,
Be placed in 30～40kHz of supersonic frequency, at 30～40 DEG C of temperature, carry out supersound extraction, extract 6～9min, finally merge squeeze the juice,
Filtrate, obtains filtrate 4, standby；
6) first filtrate 1,2,3,4 is merged, is subsequently adding through step 1) process the Maifanitum that obtains, soak 4～8min, finally according to
Secondary add through step 1) process the Pulvis Talci, nano ferriferrous oxide and the Rhizoma amorphophalli powder that obtain, and in the state of stirring ultrasound 3～
After 6min, concentration is dried, is obtained final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610937925.8A CN106492006A (en) | 2016-10-25 | 2016-10-25 | A kind of treat health product of diabetes and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610937925.8A CN106492006A (en) | 2016-10-25 | 2016-10-25 | A kind of treat health product of diabetes and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106492006A true CN106492006A (en) | 2017-03-15 |
Family
ID=58319083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610937925.8A Pending CN106492006A (en) | 2016-10-25 | 2016-10-25 | A kind of treat health product of diabetes and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106492006A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112546121A (en) * | 2020-12-28 | 2021-03-26 | 广西天天乐药业股份有限公司 | Preparation method of Yinzhiyi Yigan granules |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083487A (en) * | 2014-06-16 | 2014-10-08 | 林军庭 | Sphecomyrma traditional Chinese medicine for strengthening body resistance and preparation method |
| CN104544084A (en) * | 2015-01-19 | 2015-04-29 | 孙宁 | Health food for diabetic patients |
-
2016
- 2016-10-25 CN CN201610937925.8A patent/CN106492006A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083487A (en) * | 2014-06-16 | 2014-10-08 | 林军庭 | Sphecomyrma traditional Chinese medicine for strengthening body resistance and preparation method |
| CN104544084A (en) * | 2015-01-19 | 2015-04-29 | 孙宁 | Health food for diabetic patients |
Non-Patent Citations (1)
| Title |
|---|
| 莫娜等: "中医药治疗2型糖尿病胰岛素抵抗用药分析", 《陕西中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112546121A (en) * | 2020-12-28 | 2021-03-26 | 广西天天乐药业股份有限公司 | Preparation method of Yinzhiyi Yigan granules |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106798041A (en) | Protect liver kidney strengthening tea and preparation method thereof | |
| CN106806643A (en) | A kind of Chinese medicine composition for treating diabetes | |
| CN110151683A (en) | A kind of moistening lung to arrest cough autumn pear grease and preparation method thereof | |
| CN110214845A (en) | A method of having effects that the health preserving tea preparation for treating gout | |
| CN101518595A (en) | Medical composition with functions of lowering lipid, reducing fat and oxidation resistance and preparation method thereof | |
| CN105148077A (en) | Health preserving porridge with blood sugar decreasing effect | |
| CN111840466A (en) | Medical health-care product for enhancing immunity and assisting in treating tumors and preparation method thereof | |
| CN104946488B (en) | Health tortoise wine and preparation method thereof | |
| CN104107348A (en) | Chinese herbal medicine for blood sugar reducing, and administration method thereof | |
| CN107596197A (en) | A kind of strongly fragrant tea of tonifying Qi solution and preparation method thereof | |
| CN104435535B (en) | A kind of health medicine for treating type II diabetes | |
| CN103735663B (en) | Traditional Chinese medicine for reducing blood glucose and preparation method thereof | |
| CN106492006A (en) | A kind of treat health product of diabetes and preparation method thereof | |
| CN104162093A (en) | Traditional Chinese medicinal preparation for treating breast cancer, and preparation method thereof | |
| CN114470080A (en) | Brain-strengthening and nerve-soothing composition and preparation method thereof | |
| CN1086583C (en) | Powder and pellet for strengening yang | |
| CN106729498A (en) | A kind of albumen powder eaten after chemicotherapy and preparation method thereof | |
| CN105796971A (en) | Traditional Chinese medicine preparation for treating fatty liver and preparation method thereof | |
| CN109852519A (en) | A kind of health liquor and preparation method thereof | |
| CN108686005A (en) | A kind of medical composition and its application method for treating psoriasis | |
| CN112933180A (en) | Spray for regulating diabetes and preparation method thereof | |
| CN106362031A (en) | Health care product for preventing and treating high blood pressure and preparation method of health care product | |
| CN106822369A (en) | A kind of Antidiarrheal Chinese medicine and preparation method thereof | |
| CN113144091A (en) | A navel dropping liquid for diabetic | |
| CN118879439A (en) | A preparation method of asparagus health wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170315 |
|
| WD01 | Invention patent application deemed withdrawn after publication |